PeptiDream Inc. | Cash Flow

Fiscal year is July-June. All values JPY Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
222
1,493
2,366
2,624
3,152
Depreciation, Depletion & Amortization
74
103
143
195
513
Other Funds
-
13
-
-
81
Funds from Operations
177
1,442
1,853
1,648
3,123
Changes in Working Capital
105
55
320
118
2,100
Net Operating Cash Flow
72
1,386
1,533
1,531
1,023
Capital Expenditures
73
1,238
1,969
1,935
2,472
Purchase/Sale of Investments
1,000
2,200
1,200
-
-
Net Investing Cash Flow
3,473
962
982
1,939
4,245
Net Financing Cash Flow
18
44
1,743
46
170
Net Change in Cash
3,372
2,479
2,230
352
3,051
Free Cash Flow
1
152
415
366
1,415
Net Assets from Acquisitions
-
-
105
-
1,900
Other Sources
-
-
-
-
136
Change in Capital Stock
18
32
1,743
46
89
Exchange Rate Effect
11
87
64
11
1
Other Uses
2,400
-
108
5
10

About PeptiDream

View Profile
Address
3-25-23 Tonomachi
Kawasaki Kanagawa 210
Japan
Employees -
Website http://www.peptidream.com
Updated 07/08/2019
PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. It produces stable, and potent non-standard macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS). The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan.